drugset / Trial / NCT06002477

Attentional Mechanisms in SCD

NCT06002477

Phase 0 Recruiting 80 enrolled Vanderbilt University Medical Center
RandomizedCrossoverTriple-blindBasic science

Summary

This study will use an anticholinergic pharmacological probe to examine attention network function in SCD using EEG. The overall hypothesis is that in older adults with SCD, normal cognitive performance is maintained by compensatory attention network activity, supported by enhanced cholinergic function. The investigators anticipate that SCD will be associated with greater compensatory attention network activity and that disrupting this compensatory process through anticholinergic challenge will result in a greater negative effect on attentional performance (Attention Network Test, ANT) and attention network functioning (EEG) in older adults with greater subjective cognitive concern.

Timeline

Start
2025-06-06
Primary completion
2028-06-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mecamylamine Small molecule 20 mg Oral